Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Vaginitis--etiology”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

10 recordsLinked to original sources
PubMed1980

Pneumoperitoneum following vaginal insufflation and coitus.

A 25-year-old woman developed bilateral lower abdominal and pleuritic chest pain radiating to the shoulders 30 min after oral-genital insufflation and conventional coitus. Radiographic evaluation demonstrated a pneumoperitoneum. This was attributed to a traumatic 5-mm rent in the vaginal cuff occurring six months after post-vaginal hysterectomy. Mild symptomatology and the absence of peritoneal irritation should suggest a vaginal etiology for pneumoperitoneum, and allow consideration of conservative management. Post-coital pneumoperitoneum after abdominal hysterectomy has been reported; however, we believe this to be the first such reported case after vaginal hysterectomy and associated with oral-genital insufflation.

Adult↗
PubMed1999

[Study on etiologic agents of vaginitis].

In order to provide scientific basis for preventing and curing vaginitis, etiologic agents were examined in 354 patients with vaginitis and 115 healthy women using rapid and reliable laboratory methods. The inducements of vaginitis were analysed. The results showed that candida was only detected for the normal control group. Bacteria, candida and trichomonas were the commonest causes of vaginitis. With the increasing ages of patients with vaginitis, the incidence rates of all kinds of vaginitis were lowered. Vaginitis is associated with pregnancy, using antibiotics and contraceptive, or sexual activity.

Adult↗
PubMed1991

Bacterial vaginosis: current review with indications for asymptomatic therapy.

Bacterial vaginosis is a definable clinical entity whose exact origin is unknown. A shift in normal vaginal flora from aerobic, predominantly but not exclusively lactobacilli, to a predominantly anaerobic flora characterizes the condition. More than one half of all women with bacterial vaginosis have no symptoms. The condition is not entirely benign. The potentially pathogenic bacteria present in the vagina in large numbers place these women at risk for postoperative morbidity and adverse obstetric outcome. Sexual transmission has not been proved, but therapeutic cures sometimes require that patient and partner be treated simultaneously. Recommended therapy is with metronidazole or clindamycin and must be given for 7 days for maximal effectiveness. Recurrence of disease can be a problem.

Antifungal Agents↗
PubMed1991

Nonbarrier contraceptives and vaginitis and vaginosis.

Within the limitations of the available data, it has been reported that oral contraceptive use versus other contraceptive methods is associated with a greater or similar frequency of candidiasis, increased numbers of anaerobic microorganisms, an increased or similar frequency of chlamydia trachomatis, and a reduced frequency of bacterial vaginosis and trichomoniasis. The impact of contraceptive steroids on cellular and humoral immunologic factors may explain these observations. Intrauterine contraceptive device use is reported to be associated with an increased rate of bacterial vaginosis and anaerobic organism recovery from the vagina regardless of symptoms. Patients having a contraceptive vaginal ring were found to have the same number and types of vaginal organisms as oral contraceptive users. Levonorgestrel-releasing subdermal implant (Norplant, Wyeth-Ayerst, Philadelphia, Pa.) users have been reported to have approximately half the rate of vaginitis and vaginosis compared with that of Copper T-200 intrauterine device users.

Candidiasis, Vulvovaginal↗
PubMed1983

Vaginal infection.

Explore the source record for details and available documents.

Antifungal Agents↗
PubMed1991

Fungal vulvovaginitis.

Fungal vulvovaginitis remains one of the most frequent conditions affecting the lower genital tract. Recent advances in the understanding of the pathophysiology of the condition have improved our ability to treat recurrent or persistent cases. More clinical data have become available on the optimal duration of treatment with some of the newer antifungal agents.

Antifungal Agents↗